Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here Are the Biggest Obstacles Ahead for Pfizer and Moderna

TheMotleyFool

0 0

Here Are the Biggest Obstacles Ahead for Pfizer and Moderna

Pfizer (NYSE: PFE) recently won Emergency Use Authorization (EUA) for its coronavirus vaccine. And this week, the U.S. Food and Drug Administration (FDA) will consider an EUA for Moderna (NASDAQ: MRNA). But that doesn't mean smooth sailing ahead. In this Motley Fool Live video recorded on Dec. 11, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com contributor Adria Cimino discuss potential roadblocks for Pfizer and Moderna in the coming months.

Source Fool.com

Like: 0

MRNA

Share